• Latest Posts
In Depth 25 Apr 2023

What are biotech companies doing to tackle malaria?

Ghana becomes first country to approve University of Oxford malaria vaccine

Lumen Bioscience data show needle free spirulina-produced vaccination protects against malaria

Fight against malaria boosted by findings from a vaccine trial showing high efficacy

TikoMed drug inhibits infection of human cells by dengue, zika and yellow fever viruses

Manus Bio receives additional funding to fight malaria with biotech


KU Leuven spin-off AstriVax raises €30M for vaccine platform – first stop, yellow fever

In Depth 2 Aug 2022

The evolving arsenal against mosquito-borne diseases

Companies come together in fight against Dengue Fever

Emergex Vaccines Secures €10M to Advance Synthetic Vaccine Development

Themis Raises €40M for First Phase III Trial of a Chikungunya Vaccine 

Austrian Biotech Raises €19M to Commercialize First Chikungunya Vaccine